enzh-TWfrdeitjaptrues

The Dana-Farber Bing Center for Waldenstrom's Macroglobulinemia Web site is intended to provide general information about the program, its care and research programs, and about Waldenstrom's Macroglobulinemia and related diseases. This site also provides links to health information that may be written by Dana-Farber staff or by outside providers, and access (links) to some external Web sites for your convenience. The Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible for the availability, accuracy, or content of these external sites, nor does it endorse them.

No Medical Advice Given
This site is not an attempt to practice medicine or provide specific medical advice, nor does the use of the site establish a doctor-patient relationship. For medical treatment or answers to personal questions, we strongly encourage you to consult with a qualified health care provider. For advice about your own care, please ask your doctor!

Restrictions on Use
You assume full responsibility for using the information on this site, and you understand and agree that the Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible or liable for any claim, loss, or damage resulting from its use. While we try to keep the information on the site as accurate as possible, we disclaim any warranty concerning its accuracy, timeliness, and completeness, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose. The Dana-Farber Waldenstrom's Macroglobulinemia Program also does not warrant that access to the site will be error- or virus-free.

Copyright Infringement
Material on the Dana-Farber Waldenstrom's Macroglobulinemia Program Web site is protected by copyright law. Unless otherwise stated, users may print or download information from this site for personal, non-commercial use only. Permission to reprint or otherwise reproduce any document in whole or in part is prohibited, unless prior written consent is obtained from the copyright owner.

Latest Bing Center News

My Waldenström Macroglobulinemia, Miracle Number Three

My Waldenström Macroglobulinemia, Miracle Number Three

Dear Fellow Cancer Patient: As I believe in universal love for ALL, I’m reaching out to you, whether we have met or not, to invite you to join me in embracing the concept of medical miracles no matter what kind of cancer you have.

Read more..

Update on Bing Neel Syndrome - Shayna Sarosiek April, 2023

Update on Bing Neel Syndrome - Shayna Sarosiek April, 2023

From Bing-Neel Co-Leader & Lifeline Volunteer, Julie Davidson: "The Bing-Neel Support Group just had our Spring meeting. We featured a wonderfully informative video by Dr. Shayna Sarosiek, senior physician at the Dana-Farber Cancer Institute’s Bing Center for Waldenstrom’s Macroglobulinemia.

Read more..

2022 March Dr. Treon

2022 March Dr. Treon "Rounds" with Canadian Medical Professionals

We invited Canadian medical professionals to listen to Dr. Treon of the DFCI.  (There were 2 sessions - EST & PST)  He provided a very thorough update on the state of WM and its treatment.

Read more..

IWWM-11 (Madrid 2022) Consensus Panel Reports

IWWM-11 (Madrid 2022) Consensus Panel Reports

Consensus panel reports from the 11th International Workshop on Waldenstrom's Macroglobulinemia.

Read more..

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Researchers at Dana-Farber have put together a data atlas that includes a range of genomic, transcriptomic, epigenetic, and clinical data from patients and healthy donors to try to understand familial WM.

Read more..

Topics from the 11th IWWM Workshop in Madrid

Topics from the 11th IWWM Workshop in Madrid

Bing Center WM experts discuss various topics from the 11th IWWM in Madrid.

Read more..

Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients

Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients

What should you know if you or a loved one has been diagnosed with Waldenström macroglobulinemia (WM)? Dr. Shayna Sarosiek of the Dana-Farber Cancer Institute shares key advice.

Read more..

Talking with your Waldenstrom's Macroglobulinemia Patients

Talking with your Waldenstrom's Macroglobulinemia Patients

This document, written by Drs. Jorge Castillo and Shayna Sarosiek, provides a reference guide to assist medical professionals in discussions with WM patients. Patients can give this booklet to their PCP, oncologist, or other health care provider in order to help familiarize them with this uncommon disease.

Read more..

2022 ASH Conference Report: Waldenstrom Macroglobulinemia

2022 ASH Conference Report: Waldenstrom Macroglobulinemia

From the 64th ASH Annual Meeting, Jorge Castillo, MD, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, updates our Waldenström patient community on important research results presented this year, offers guidance on finding relevant clinical trials, and highlights what to look for in the coming year.

Read more..

RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease

RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease

RECORDING NOW AVIALABLE! Join IWMF on ZOOM for this very important topic that affects everyone with a WM diagnosis! Dr. Jorge Castillo presents - Treatments, Trials, and Hope – for ALL Stages of Disease. Dr. Castillo is a GLOBAL SPECIALIST IN Waldenstrom's Macroglobulinemia (WM) AND Clinical Director of the Bing Center Clinic (for WM) at Dana-Farber Cancer Institute.

Read more..